Full-Time

Associate Director

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

201-500 employees

Develops precision oncology therapies

Biotechnology

Compensation Overview

$160,000 - $200,000Annually

+ Competitive cash compensation + Robust equity awards + Significant learning and development opportunities

Senior

San Carlos, CA, USA

Required Skills
Management
Requirements
  • BA. or BSc. in Life Sciences with a MSc. or MBA or Ph.D.
  • 5 years' experience in the biotech/pharmaceutical industry
  • 2 years' direct development project management experience
  • PMP (Project Management Professional) or other PM certification
  • Experience in the Oncology therapeutic area
  • Understanding of the clinical drug development process and regulations
  • Expertise in project management practices, tools, and methodology
  • Excellent interpersonal skills
  • Strong computer proficiency with MS Office suite, SharePoint, and similar document archiving systems
Responsibilities
  • Understand the program strategy and stakeholders
  • Manage the integrated project plan and project assumptions
  • Identify critical path activities, resource constraints, risks, and conflicts
  • Contribute to scenario planning
  • Manage the preparation, review, editing, and submission of project documents
  • Lead an efficient information flow within the project team
  • Practice effective meeting and information management
  • Facilitate project team meetings
  • Partner with the sub-team leads to ensure high-level sustainable performance
  • Recommend and implement opportunities for streamlining team and business processes
  • Drive adoption of project management systems and best practices
  • Onboard and train new team members
  • Support new programs and special projects

Revolution Medicines specializes in developing precision oncology therapies, particularly RAS(ON) inhibitors and RAS Companion inhibitors, with their lead product candidate, RMC-4630, currently in a Phase 1/2 clinical program targeting specific oncogenic mutations in various tumor types. The company's main focus is on developing these therapies to target specific oncogenic mutations in different tumor types, utilizing precision oncology technologies.

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

22%

1 year growth

50%

2 year growth

103%